107 related articles for article (PubMed ID: 17890100)
1. Prion removal by nanofiltration under different experimental conditions.
Yunoki M; Tanaka H; Urayama T; Hattori S; Ohtani M; Ohkubo Y; Kawabata Y; Miyatake Y; Nanjo A; Iwao E; Morita M; Wilson E; MacLean C; Ikuta K
Biologicals; 2008 Jan; 36(1):27-36. PubMed ID: 17890100
[TBL] [Abstract][Full Text] [Related]
2. Infectious prion protein in the filtrate even after 15 nm filtration.
Yunoki M; Tanaka H; Urayama T; Kanai Y; Nishida A; Yoshikawa M; Ohkubo Y; Kawabata Y; Hagiwara K; Ikuta K
Biologicals; 2010 Mar; 38(2):311-3. PubMed ID: 19931469
[TBL] [Abstract][Full Text] [Related]
3. Capacity of the manufacturing process of Flebogamma(®) DIF, a new human high purity intravenous immunoglobulin, to remove a TSE model-agent.
Diez JM; Caballero S; Belda F; Otegui M; Gajardo R; Jorquera JI
Biologicals; 2010 Nov; 38(6):670-4. PubMed ID: 20863716
[TBL] [Abstract][Full Text] [Related]
4. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation.
Berardi VA; Cardone F; Valanzano A; Lu M; Pocchiari M
Transfusion; 2006 Apr; 46(4):652-8. PubMed ID: 16584444
[TBL] [Abstract][Full Text] [Related]
5. Elimination capacity of a TSE-model agent in the manufacturing process of Alphanate/Fanhdi, a human factor VIII/VWF complex concentrate.
Diez JM; Caballero S; Belda FJ; Otegui M; Gajardo R; Jorquera JI
Haemophilia; 2009 Nov; 15(6):1249-57. PubMed ID: 19563480
[TBL] [Abstract][Full Text] [Related]
6. Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates.
Sowemimo-Coker SO; Pesci S; Andrade F; Kim A; Kascsak RB; Kascsak RJ; Meeker C; Carp R
Vox Sang; 2006 May; 90(4):265-75. PubMed ID: 16635068
[TBL] [Abstract][Full Text] [Related]
7. TSE clearance during plasma products separation process by Gradiflow(TM).
Wang K; Johnson A; Obradovic M; Anderson G; Maclean C; Nair H
Biologicals; 2005 Jun; 33(2):87-94. PubMed ID: 15939286
[TBL] [Abstract][Full Text] [Related]
8. Comparison of nanofiltration efficacy in reducing infectivity of centrifuged versus ultracentrifuged 263K scrapie-infected brain homogenates in "spiked" albumin solutions.
Cardone F; Simoneau S; Arzel A; Puopolo M; Berardi VA; Abdel-Haq H; Galeno R; De Pascalis A; Sbriccoli M; Graziano S; Valanzano A; Porte P; Diringer H; Brown P; Flan B; Pocchiari M
Transfusion; 2012 May; 52(5):953-62. PubMed ID: 22082124
[TBL] [Abstract][Full Text] [Related]
9. Prion-removal capacity of chromatographic and ethanol precipitation steps used in the production of albumin and immunoglobulins.
Thyer J; Unal A; Thomas P; Eaton B; Bhashyam R; Ortenburg J; Uren E; Middleton D; Selleck P; Maher D
Vox Sang; 2006 Nov; 91(4):292-300. PubMed ID: 17105604
[TBL] [Abstract][Full Text] [Related]
10. Removal of exogenous (spiked) and endogenous prion infectivity from red cells with a new prototype of leukoreduction filter.
Sowemimo-Coker S; Kascsak R; Kim A; Andrade F; Pesci S; Kascsak R; Meeker C; Carp R; Brown P
Transfusion; 2005 Dec; 45(12):1839-44. PubMed ID: 16371036
[TBL] [Abstract][Full Text] [Related]
11. [Establishment of a prion disease PrP(Sc) panel from the brain tissues of experimental hamsters infected with scrapie agent 263K].
Zhang BY; Tian C; Han J; Gao C; Shi Q; Jiang HY; Zhou W; Dong XP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):321-3. PubMed ID: 19469162
[TBL] [Abstract][Full Text] [Related]
12. [Establishment of a protein misfolding cyclic amplification for PrPSc].
Han J; Han L; Shi Q; Shi S; Wang X; Zhang BY; Dong XP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):202-4. PubMed ID: 17971920
[TBL] [Abstract][Full Text] [Related]
13. Assessment of prion reduction filters in decreasing infectivity of ultracentrifuged 263K scrapie-infected brain homogenates in "spiked" human blood and red blood cells.
Cardone F; Sowemimo-Coker S; Abdel-Haq H; Sbriccoli M; Graziano S; Valanzano A; Berardi VA; Galeno R; Puopolo M; Pocchiari M
Transfusion; 2014 Apr; 54(4):990-5. PubMed ID: 23915063
[TBL] [Abstract][Full Text] [Related]
14. Removal of prion challenge from an immune globulin preparation by use of a size-exclusion filter.
Van Holten RW; Autenrieth S; Boose JA; Hsieh WT; Dolan S
Transfusion; 2002 Aug; 42(8):999-1004. PubMed ID: 12385410
[TBL] [Abstract][Full Text] [Related]
15. Degradation of scrapie associated prion protein (PrPSc) by the gastrointestinal microbiota of cattle.
Scherbel C; Pichner R; Groschup MH; Mueller-Hellwig S; Scherer S; Dietrich R; Maertlbauer E; Gareis M
Vet Res; 2006; 37(5):695-703. PubMed ID: 16820134
[TBL] [Abstract][Full Text] [Related]
16. In vitro infectivity assay for prion titration for application to the evaluation of the prion removal capacity of biological products manufacturing processes.
You B; Aubin JT; Le-Hir G; Arzel A; Laude H; Flan B
J Virol Methods; 2010 Mar; 164(1-2):1-6. PubMed ID: 19854223
[TBL] [Abstract][Full Text] [Related]
17. Scrapie removal using Planova virus removal filters.
Tateishi J; Kitamoto T; Mohri S; Satoh S; Sato T; Shepherd A; Macnaughton MR
Biologicals; 2001 Mar; 29(1):17-25. PubMed ID: 11482889
[TBL] [Abstract][Full Text] [Related]
18. CJD PrPsc removal by nanofiltration process: application to a therapeutic immunoglobulin solution (Lymphoglobuline).
Truchot L; Arnaud T; Bloy C; Perret-Liaudet A
Biologicals; 2006 Sep; 34(3):227-31. PubMed ID: 16490361
[TBL] [Abstract][Full Text] [Related]
19. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
[TBL] [Abstract][Full Text] [Related]
20. A solvent/detergent-treated and 15-nm filtered factor VIII: a new safety standard for plasma-derived coagulation factor concentrates.
Chtourou S; Porte P; Nogré M; Bihoreau N; Cheesman E; Samor B; Sauger A; Raut S; Mazurier C
Vox Sang; 2007 May; 92(4):327-37. PubMed ID: 17456157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
